Phenotypic Characterization and rhGH Therapeutic Response in ACAN Children with Short Stature: A Real-World Study
- 24 July 2026
- journal article
- Published by Elsevier in Endocrine Practice
Abstract
No abstract availableFunding Information
- Medical Science and Technology Development Foundation, Nanjing Municipality Health Bureau (YKK20126)
This publication has 25 references indexed in Scilit:
- Clinical Characteristics of Pathogenic ACAN Variants and 3-Year Response to Growth Hormone Treatment: Real-World DataHormone Research in Paediatrics, 2024
- Short stature with precocious puberty caused by aggrecan gene mutation A case reportMedicine, 2020
- Pathogenic gene screening in 91 Chinese patients with short stature of unknown etiology with a targeted next-generation sequencing panelBMC Medical Genetics, 2018
- Novel aggrecan variant, p. Gln2364Pro, causes severe familial nonsyndromic adult short stature and poor growth hormone response in Chinese childrenBMC Medical Genetics, 2018
- Heterozygous aggrecan variants are associated with short stature and brachydactyly: Description of 16 probands and a review of the literatureClinical Endocrinology, 2018
- Genetic screening confirms heterozygous mutations in ACAN as a major cause of idiopathic short statureScientific Reports, 2017
- Novel pathogenic ACAN variants in non-syndromic short stature patientsClinica Chimica Acta, 2017
- Identification of a novel heterozygous mutation of the Aggrecan gene in a family with idiopathic short stature and multiple intervertebral disc herniationJournal of Human Genetics, 2017
- Early recognition of growth abnormalities permitting early interventionActa Paediatrica, 2013
- A Missense Mutation in the Aggrecan C-type Lectin Domain Disrupts Extracellular Matrix Interactions and Causes Dominant Familial Osteochondritis DissecansThe American Journal of Human Genetics, 2010